Ascendis Pharma A/S Forecast and Stock Analysis
Technical ASND stock analysis for April 24, 2019.
Ascendis Pharma A/S fell by -3.65% in the last day from $112.12 to $108.03 The price has been going up and down for this period, and there has been a -9.32% loss for the last 2 weeks. Volume has increased in the last day by 45 903 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 383 370 shares bought and sold for approximately $41.42 million.
Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the ASND stock was $108.03. This is 3.65% less than the trading day before Tuesday, 23rd Apr 2019.
During day the stock fluctuated 5.77% from a day low at $106.76 to a day high of $112.92.
30 day high of the ASND stock price was $124.72 and low was $105.02.
90 day high was $131.76 and low was $66.12.
52 week high for the Ascendis Pharma A/S - $131.76 and low - $53.21.
Ascendis Pharma A/S lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $107.09 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 63.01% during the next 3 months and, with 90% probability hold a price between $174.57 and $262.67 at the end of this period.
There are few to none technical positive signals at the moment. Ascendis Pharma A/S holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $109.82 and $118.11. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday April 23, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSI14 is 37 and the stock is currently not being overbought or oversold
Support & Resistance
Ascendis Pharma A/S finds support from accumulated volume at $107.75.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $6.16 (5.77%) between high and low. For the last week, the stock has had a daily average volatility of 5.04%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
The Ascendis Pharma A/S stock holds several negative signals and despite the positive trend we believe Ascendis Pharma A/S will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ASND $108.03 ($-4.09 -3.65%)|
ASND is down $4.09 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ASND based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ASND analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us